Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Financiere de TubizeCHIX:TUBB 43 5-Year Yield-on-Cost % is 0.79 as of Jul. 24, 2026. GuruFocus rates CHIX:TUBB with a GF Score™ of 43/100. The stock has 1 warning sign investors should review. Among 151 Biotechnology companies, Financiere de Tubize ranks worse than 69.54% on this metric.
Financiere de Tubize's yield on cost for the quarter that ended in Dec. 2025 was 0.79.
The historical rank and industry rank for Financiere de Tubize's 5-Year Yield-on-Cost % or its related term are showing as below:
CHIX:TUBb'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.79
Current: 0.79
During the past 13 years, Financiere de Tubize's highest Yield on Cost was 0.79. The lowest was 0.00. And the median was 0.00.
CHIX:TUBb's 5-Year Yield-on-Cost % is ranked worse than 69.54% of 151
companies
in the Biotechnology industry
Industry Median: 1.73
vs CHIX:TUBb: 0.79
Financiere de Tubize (CHIX:TUBb) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Financiere de Tubize 5-Year Yield-on-Cost % Related Terms
CHIX:TUBB vs VRTX, REGN, ALNY: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Financiere de Tubize's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Financiere de Tubize 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Financiere de Tubize's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Financiere de Tubize's 5-Year Yield-on-Cost % falls into.
Financiere de Tubize 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Financiere de Tubize (CHIX:TUBB) has a 5-Year Yield-on-Cost % of 0.79 as of Jul. 24, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Financiere de Tubize and its competitors. According to the industry distribution chart, Financiere de Tubize ranks #105 out of 151 companies in the Biotechnology industry, placing it in the top 69.5%.
Is Financiere de Tubize's 5-Year Yield-on-Cost % too high?
Financiere de Tubize's current 5-Year Yield-on-Cost % is 0.79. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.73. Financiere de Tubize's value of 0.79 is 54.3% below this industry median. Based on the distribution chart, Financiere de Tubize ranks #105 out of 151 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Financiere de Tubize has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Financiere de Tubize ranks #105 out of 151 companies for 5-Year Yield-on-Cost %. This places Financiere de Tubize in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.73. Financiere de Tubize's value of 0.79 is 54.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.73, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Financiere de Tubize's current 5-Year Yield-on-Cost % of 0.79 is 54.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Financiere de Tubize and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Financiere de Tubize's current 5-Year Yield-on-Cost % is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (CHIX:TUBB) has a current 5-Year Yield-on-Cost % of 0.79. The current 5-Year Yield-on-Cost % is 0.79 and 54.3% below the Biotechnology industry median of 1.73. Financiere de Tubize's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Financiere de Tubize (CHIX:TUBB), the current 5-Year Yield-on-Cost % is 0.79 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
43GF Score
Get the complete analysis for CHIX:TUBB
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:TUBB has been successfully added to your 
